GlycoNet researchers find that CD33 isoforms on the surface of the brain’s microglia can have opposing effects, providing protection or increased susceptibility to Alzheimer’s Disease.
GlycoNet researchers find that CD33 isoforms on the surface of the brain’s microglia can have opposing effects, providing protection or increased susceptibility to Alzheimer’s Disease.